Literature DB >> 10657007

Nitric oxide, iNOS, and inflammation in cystic fibrosis.

D Downey, J S Elborn.   

Abstract

Nitric oxide (NO) is produced from three isoforms of nitric oxide synthase (NOS), neuronal (nNOS), endothelial (eNOS) and inducible (iNOS). Cystic fibrosis (CF) patients have an increased bacterial load in the airways which stimulates iNOS and therefore NO production. Upregulation of iNOS in normal epithelial cells protects the lung from damage, but in CF cells, iNOS is not upregulated and NO production is reduced. Reduced iNOS expression is associated with neutrophil sequestration in the lung, thus increasing the potential damage from neutrophil proteases and reactive oxygen species. In contrast, high concentrations of NO may augment the inflammatory process in acute lung injury from sepsis. Meng et al. have shown that cystic fibrosis epithelial cells, when stimulated by a cytokine mix and co-cultured with activated neutrophils, have reduced iNOS expression compared to normal epithelial cells. Although iNOS expression may not accurately reflect activity and NO production may arise from elsewhere, this study suggests that reduced iNOS expression may play a part in the pathophysiological processes in cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10657007     DOI: 10.1002/(SICI)1096-9896(200002)190:2<115::AID-PATH491>3.0.CO;2-V

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  6 in total

Review 1.  Exhaled nitric oxide measurements: clinical application and interpretation.

Authors:  D R Taylor; M W Pijnenburg; A D Smith; J C De Jongste
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

2.  Abrogation of anti-inflammatory transcription factor LKLF in neutrophil-dominated airways.

Authors:  Milene T Saavedra; Abby D Patterson; James West; Scott H Randell; David W Riches; Ken C Malcolm; Carlyne D Cool; Jerry A Nick; Charles A Dinarello
Journal:  Am J Respir Cell Mol Biol       Date:  2008-01-24       Impact factor: 6.914

Review 3.  Arginase and pulmonary diseases.

Authors:  Harm Maarsingh; Tonio Pera; Herman Meurs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-24       Impact factor: 3.000

4.  Assessment of airway inflammation with exhaled NO measurement.

Authors:  E Hatziagorou; J Tsanakas
Journal:  Hippokratia       Date:  2007-04       Impact factor: 0.471

5.  The anti-inflammatory activities of ethanol extract from Dan-Lou prescription in vivo and in vitro.

Authors:  Li-Na Gao; Xin Zhou; Yi Zhang; Yuan-Lu Cui; Chun-Quan Yu; Shan Gao
Journal:  BMC Complement Altern Med       Date:  2015-09-09       Impact factor: 3.659

6.  2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage function.

Authors:  Mao Wang; Alex G Gauthier; Thomas P Kennedy; Haichao Wang; Uday Kiran Velagapudi; Tanaji T Talele; Mosi Lin; Jiaqi Wu; LeeAnne Daley; Xiaojing Yang; Vivek Patel; Sung Soo Mun; Charles R Ashby; Lin L Mantell
Journal:  Mol Med       Date:  2021-07-16       Impact factor: 6.354

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.